- https://corvuspharma.gcs-web.com/
- https://corvuspharma.gcs-web.com/sec-filings
- https://corvuspharma.gcs-web.com/press-releases
- https://corvuspharma.gcs-web.com/calendar-events
- https://corvuspharma.gcs-web.com/presentations
- https://corvuspharma.gcs-web.com/analyst-coverage
- https://corvuspharma.gcs-web.com/governance-documents
- https://corvuspharma.gcs-web.com/committee-composition
- https://corvuspharma.gcs-web.com/stock-quote
- https://corvuspharma.gcs-web.com/stock-chart
- https://corvuspharma.gcs-web.com/historic-prices
- https://corvuspharma.gcs-web.com/investor-calculator
- https://corvuspharma.gcs-web.com/stockholder-faq
- https://corvuspharma.gcs-web.com/information-request
- http://www.hanechow.com
الأحد، 21 يوليو 2019
Corvus Pharmaceuticals | refractory renal cell carcinoma | non-small cell lung cancer
الاشتراك في:
تعليقات الرسالة (Atom)
ليست هناك تعليقات:
إرسال تعليق